Biosimilars Market Projected to Reach USD 97.32 Billion by 2030, Driven by Expanding Therapeutic Applications and Strategic Collaborations

Mordor Intelligence has published a new report on the Biosimilars Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global biosimilars market is experiencing significant growth, with projections indicating an increase from USD 41.97 billion in 2025 to USD 97.32 billion by 2030, reflecting a compound annual growth rate (CAGR) of 18.32%. This expansion is attributed to the broadening of biosimilars' therapeutic applications, strategic partnerships, and increasing demand for cost-effective healthcare solutions.

Biosimilars, which are biologic medical products highly similar to already approved reference products, are gaining prominence in the global pharmaceutical landscape. Their development and adoption are reshaping treatment paradigms, particularly in areas such as oncology, autoimmune disorders, and ophthalmology. The market's growth is further propelled by the expiration of patents for several blockbuster biologic drugs, enabling the introduction of biosimilars that offer comparable efficacy and safety profiles at reduced costs.

Report Overview: https://www.mordorintelligence.com/industry-reports/global-biosimilars-market-industry?utm_source=openpr

Key Trends

1. Expansion into Specialized Therapeutic Areas

Initially concentrated in oncology and autoimmune diseases, biosimilars are now making inroads into specialized fields like ophthalmology. For instance, FDA-approved biosimilars such as Byooviz by Biogen and Cimerli by Coherus Biosciences have been introduced for treating retinal diseases, marking a significant milestone in the adoption of biosimilars in specialized medicine.

2. Strategic Collaborations Enhancing Market Reach

Partnerships between biosimilar developers and contract manufacturing organizations (CMOs) are strengthening the supply chain and ensuring the scalability of production. For example, collaborations between companies like Samsung Biologics and Pfizer are expanding manufacturing capacities to support a diverse biosimilar portfolio, including treatments for oncology, inflammation, and immunology.

3. Increasing Regulatory Support

Regulatory agencies worldwide are providing clearer pathways for biosimilar approvals, fostering a more favorable environment for their development and market entry. This support is crucial in accelerating the availability of biosimilars, thereby enhancing patient access to affordable treatment options.

Market Segmentation

By Product Class:

Monoclonal Antibodies: Dominating the market, these are used in various therapeutic areas, including oncology and autoimmune diseases.

Recombinant Hormones: Used in treating conditions like growth hormone deficiencies

Immunomodulators: Affect the immune system's functioning, relevant in autoimmune disorders.

Anti-Inflammatory Agents: Target inflammation-related conditions.

Other Product Classes: Including enzymes and blood factors.

By Application:

Oncology: The largest segment, driven by the high prevalence of cancer and the need for cost-effective treatments.

Blood Disorders: Conditions like anemia require biosimilar therapies.

Growth Hormonal Deficiency: Treatment options for growth hormone deficiencies.

Chronic and Autoimmune Disorders: Including rheumatoid arthritis and Crohn's disease.

Other Applications: Such as ophthalmology and dermatology.

By Geography:

North America: The largest market, owing to advanced healthcare infrastructure and high adoption rates.

Asia-Pacific: The fastest-growing region, driven by increasing healthcare needs and improving regulatory frameworks.

Europe: A significant market with established biosimilar policies.

Middle East and Africa: Emerging markets with growing healthcare investments.

South America: Developing markets with expanding healthcare access.

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

The biosimilars market is characterized by the presence of several key players:

Samsung Bioepis Co., Ltd.

Pfizer Inc.

Coherus Biosciences, Inc

Amgen Inc

Novartis AG

These companies are actively engaged in the development, manufacturing, and marketing of biosimilars, contributing to the market expansion and diversification of treatment options available to patients.

Conclusion

The global biosimilars market is poised for significant growth, driven by the expansion into specialized therapeutic areas, strategic collaborations, and increasing regulatory support. As the market evolves, biosimilars are expected to play a crucial role in enhancing patients' access to affordable treatments, thereby contributing to the sustainability of healthcare systems worldwide. Stakeholders across the pharmaceutical industry are encouraged to engage in this dynamic sector to capitalize on emerging opportunities and address the growing demand for cost-effective therapeutic solutions.

Industry Related Reports

Biosimilar Contract Manufacturing Market : The Biosimilar Contract Manufacturing Market report segments the industry based on Production Technology (Mammalian, Microbial), Product Type (Recombinant Non-glycosylated Proteins, and others), Application Areas (Oncology, Infectious Diseases, Blood Disorders, etc.), Service Categories (Upstream Processing, Downstream Processing, and others), and Regional Markets (North America, Europe, and others).

Get More Insights: https://www.mordorintelligence.com/industry-reports/biosimilar-contract-manufacturing-market?utm_source=openpr

Biologics CDMO Market: The Biologics CDMO Market report is segmented by Type (Mammalian and Non-Mammalian (Microbial)), Product Category (Biologics (Monoclonal Antibodies, Recombinant Proteins, Antisense and Molecular Therapy, Vaccines, and Other Biologics) and Biosimilars), and Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa). Market Sizes and Forecasts are presented in terms of Value (USD) for each of the aforementioned segments.

Get More Insights: https://www.mordorintelligence.com/industry-reports/biologics-contract-development-and-manufacturing-organization-cdmo-market?utm_source=openpr

Filgrastim Market: The Filgrastim Market is segmented by Drug Type (Biologics and Biosimilars), Distribution Channel (Offline Pharmacies and Online Pharmacies), and Region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report provides the market value (USD) for each of the above segments.

Get More Insights: https://www.mordorintelligence.com/industry-reports/filgrastim-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.